Brasada Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-13,066
Closed -$1.93M 152
2020
Q3
$1.93M Buy
13,066
+5,386
+70% +$834K 0.49% 58
2020
Q2
$1.26M Buy
+7,680
New +$1.18M 0.35% 68
2018
Q4
Sell
-33
Closed -$4K 335
2018
Q3
$4K Buy
+33
New +$3.3K ﹤0.01% 343
2018
Q1
Sell
-400
Closed -$34K 285
2017
Q4
$34K Buy
+400
New +$34K 0.01% 204

Other funds holding LLY

Brasada Capital Management's LLY Position: Q4 2020 in Review

Brasada Capital Management sold out of Eli Lilly (LLY) in Q4 2020, closing a stake of 13,066 shares — an estimated $1.93M sold.

Brasada Capital Management first reported a position in LLY in Q4 2017 and held it in 4 quarters. The position peaked at $1.93M in Q3 2020. 1,887 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

  • Brasada Capital Management reported no remaining Eli Lilly position as of Q4 2020 after selling out during the quarter.
  • Brasada Capital Management sold 13,066 Eli Lilly shares in Q4 2020, an estimated $1.93M.
  • Brasada Capital Management first reported a position in Eli Lilly in Q4 2017 and held it in 4 quarters.
  • Brasada Capital Management's Eli Lilly position peaked at $1.93M in Q3 2020.
  • 1,887 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on Brasada Capital Management's 13F filing for Q4 2020, filed 5 Feb 2021.